| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of Reimbursement for Outpatient Intraperitoneal Chemotherapy Versus Intravenous Therapy for Ovarian Cancer
|
Schink, Julian C.
|
|
2008
|
|
1 |
p. 75-77
3 p.
|
artikel
|
| 2 |
A Proposal to Improve Treatment of Patients with Gynecologic Cancer in Developing Countries
|
Hemida, Reda A.
|
|
2009
|
|
1 |
p. 38-43
6 p.
|
artikel
|
| 3 |
Clinical Indications for Human Papillomavirus Vaccination
|
Herzog, Thomas J.
|
|
2008
|
|
1 |
p. 36-39
4 p.
|
artikel
|
| 4 |
Coexistent Uterine Choriocarcinoma and Carcinosarcoma With Lung Metastases
|
Hugon-Rodin, Justine
|
|
2010
|
|
1 |
p. 56-58
3 p.
|
artikel
|
| 5 |
CON: Dose-dense Paclitaxel at 80 mg/m2 Weekly in Combination with Carboplatin AUC-6 Every Three Weeks Should Not be Considered Standard of Care in the Front Line Management of Ovarian Cancer
|
Mannel, Robert
|
|
2011
|
|
1 |
p. 4-6
3 p.
|
artikel
|
| 6 |
CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not Be Treated With Cisplatin Plus Paclitaxel
|
Thigpen, J. Tate
|
|
2010
|
|
1 |
p. 18-20
3 p.
|
artikel
|
| 7 |
CON: Patients with Recurrent Ovarian Carcinoma Should Not Be Treated with Antiangiogenic Agents in Combination with Chemotherapy
|
Sabbatini, Paul
|
|
2009
|
|
1 |
p. 16-18
3 p.
|
artikel
|
| 8 |
CON: Secondary Surgical Debulking Is Not an Acceptable Option in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
|
Thigpen, J. Tate
|
|
2009
|
|
1 |
p. 21-23
3 p.
|
artikel
|
| 9 |
CON: Systemic Therapy for All Endometrial Carcinomas Should Not Be Paclitaxel Plus Carboplatin
|
Thigpen, J. Tate
|
|
2010
|
|
1 |
p. 25-28
4 p.
|
artikel
|
| 10 |
DNA Repair–Based Mechanisms of Platinum Resistance in Epithelial Ovarian Cancer: From Bench to Bedside
|
Díaz-Padilla, Iván
|
|
2010
|
|
1 |
p. 29-35
7 p.
|
artikel
|
| 11 |
Do Patients With Platinum-Resistant Epithelial Ovarian Cancer Benefit From Second-line Chemotherapy?
|
Hashimoto, Kenji
|
|
2010
|
|
1 |
p. 36-40
5 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2011
|
|
1 |
p. A1-
1 p.
|
artikel
|
| 13 |
Erythropoiesis-Stimulating Agents and the Practice of Gynecologic Oncology
|
Glaspy, John
|
|
2008
|
|
1 |
p. 44-53
10 p.
|
artikel
|
| 14 |
Getting Personal! The Treatment of Epithelial Ovarian Cancer
|
Farley, John
|
|
2009
|
|
1 |
p. 9-11
3 p.
|
artikel
|
| 15 |
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study
|
Ray-Coquard, Isabelle
|
|
2008
|
|
1 |
p. 54-59
6 p.
|
artikel
|
| 16 |
Highlights from: The Annual Meeting of the Society of Gynecologic Oncologists; March 9–12, 2008; Tampa, FL
|
Ranganathan, Aarati
|
|
2008
|
|
1 |
p. 10-14
5 p.
|
artikel
|
| 17 |
Intraperitoneal Chemotherapy for Stage III Ovarian Cancer Using the Gynecologic Oncology Group Protocol 172 Intraperitoneal Regimen: Effect of Supportive Care Using Aprepitant and Pegfilgrastim on Treatment Completion Rate
|
Guile, Matthew W.
|
|
2008
|
|
1 |
p. 68-71
4 p.
|
artikel
|
| 18 |
Intraperitoneal Chemotherapy: Practicality Versus Theory
|
Spirtos, Nick M.
|
|
2008
|
|
1 |
p. 72-74
3 p.
|
artikel
|
| 19 |
Intraperitoneal Chemotherapy: The Standard or an Option?
|
Thigpen, J. Tate
|
|
2008
|
|
1 |
p. 8-9
2 p.
|
artikel
|
| 20 |
Investigating Chemotherapy-Induced Nausea and Vomiting
|
Plaxe, Steven C.
|
|
2008
|
|
1 |
p. 66-67
2 p.
|
artikel
|
| 21 |
Isolated Myeloid Sarcoma of the Vulva
|
Isonishi, Seiji
|
|
2011
|
|
1 |
p. 49-51
3 p.
|
artikel
|
| 22 |
Is Serum Albumin an Independent Predictor of Survival in Ovarian Cancer?
|
Gupta, Digant
|
|
2009
|
|
1 |
p. 52-56
5 p.
|
artikel
|
| 23 |
Is the Adjustment of Serum Creatinine Level from < 0.6 mg/dL to 0.6 mg/dL Justified in Estimating Carboplatin Clearance Calculated by the Jelliffe Formula?
|
Nagao, Shoji
|
|
2009
|
|
1 |
p. 48-51
4 p.
|
artikel
|
| 24 |
Luteinized Fibroma of the Ovary With Minor Sex Cord Elements: An Incidental Finding
|
Sherwani, Rana K.
|
|
2011
|
|
1 |
p. 41-43
3 p.
|
artikel
|
| 25 |
Lysophosphatidic Acid in Patients With Ovarian Cancer
|
Sedláková, Iva
|
|
2010
|
|
1 |
p. 41-46
6 p.
|
artikel
|
| 26 |
Maintenance Therapy in Epithelial Ovarian Cancer: Rationale and Results
|
Markman, Maurie
|
|
2008
|
|
1 |
p. 40-43
4 p.
|
artikel
|
| 27 |
Making of a Phase III Study in Recurrent Ovarian Cancer: The Odyssey of GOG 213
|
Coleman, Robert L.
|
|
2008
|
|
1 |
p. 78-80
3 p.
|
artikel
|
| 28 |
Metastatic Squamous Cell Carcinoma of the Cervix Presenting as an Adnexal Neoplasm
|
Katsnelson, Marina
|
|
2011
|
|
1 |
p. 47-48
2 p.
|
artikel
|
| 29 |
Nutritional Intervention in Ovarian Cancer: Failure to Appreciate the Fundamental Distinction Between a Prognostic and a Predictive Clinical Parameter
|
Markman, Maurie
|
|
2010
|
|
1 |
p. 7-8
2 p.
|
artikel
|
| 30 |
Outpatient Intraperitoneal Chemotherapy for All Stages of Ovarian, Fallopian Tube, and Peritoneal Cancers: A Pilot Study
|
Silver, David
|
|
2011
|
|
1 |
p. 7-11
5 p.
|
artikel
|
| 31 |
Ovarian Cancer in a Man?
|
Sumrall, Ashley
|
|
2009
|
|
1 |
p. 57-59
3 p.
|
artikel
|
| 32 |
PRO: Dose-dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer
|
Coleman, Robert L.
|
|
2011
|
|
1 |
p. 1-3
3 p.
|
artikel
|
| 33 |
PRO: Patients With Metastatic/Recurrent Cervical Cancer Should Be Treated With Cisplatin Plus Paclitaxel
|
Tewari, Krishnansu S.
|
|
2010
|
|
1 |
p. 14-17
4 p.
|
artikel
|
| 34 |
PRO: Patients with Recurrent Ovarian Cancer Should Be Treated with Antiangiogenic Agents in Combination with Chemotherapy
|
Boruta, David
|
|
2009
|
|
1 |
p. 12-15
4 p.
|
artikel
|
| 35 |
PRO: Secondary Surgical Debulking Is an Acceptable Option in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
|
Nagel, Christa I.
|
|
2009
|
|
1 |
p. 19-20
2 p.
|
artikel
|
| 36 |
PRO: Systemic Therapy for All Endometrial Cancers Should Be Paclitaxel Plus Carboplatin
|
Powell, Matthew A.
|
|
2010
|
|
1 |
p. 21-24
4 p.
|
artikel
|
| 37 |
Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus
|
Timmins III, Patrick
|
|
2008
|
|
1 |
p. 60-65
6 p.
|
artikel
|
| 38 |
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
|
Horowitz, Neil S.
|
|
2011
|
|
1 |
p. 26-33
8 p.
|
artikel
|
| 39 |
Safety of Bevacizumab in Advanced Ovarian and Müllerian Cancers: A Review
|
Campos, Susana M.
|
|
2009
|
|
1 |
p. 31-37
7 p.
|
artikel
|
| 40 |
Secondary Debulking Including Nephrectomy in Recurrent Uterine Carcinosarcoma: A Case Report
|
Kushnir, Christina L.
|
|
2010
|
|
1 |
p. 59-61
3 p.
|
artikel
|
| 41 |
Selected Trials in Gynecologic Cancer; Currently Open for Enrollment in the United States
|
Thigpen, J. Tate
|
|
2010
|
|
1 |
p. 62-63
2 p.
|
artikel
|
| 42 |
Spontaneous Renal Pelvis Rupture Due To Ovarian Carcinoma: Case Report
|
Çıracı, Saliha
|
|
2011
|
|
1 |
p. 38-40
3 p.
|
artikel
|
| 43 |
Successful Treatment of Metastatic Squamous Cell Carcinoma of the Ovary Arising Within a Mature Cystic Teratoma
|
Ford, Tyler C.
|
|
2011
|
|
1 |
p. 44-46
3 p.
|
artikel
|
| 44 |
Table of Contents
|
|
|
2011
|
|
1 |
p. A2-A3
nvt p.
|
artikel
|
| 45 |
The Clinical Impact of Computed Tomography Immediately Following Primary Chemotherapy in Patients With Epithelial Ovarian Cancer
|
Whitworth, Jenny M.
|
|
2010
|
|
1 |
p. 52-55
4 p.
|
artikel
|
| 46 |
The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer
|
Bevis, Kerri S.
|
|
2011
|
|
1 |
p. 34-37
4 p.
|
artikel
|
| 47 |
The Prognostic Value of Syndecan-1 in Ovarian Cancer Patients with Long-Term Follow up
|
Madsen, Christine Vestergaard
|
|
2011
|
|
1 |
p. 12-18
7 p.
|
artikel
|
| 48 |
The 41st Annual Meeting on Women’s Cancer Conducted by the Society of Gynecologic Oncologists
|
Ranganathan, Aarati
|
|
2010
|
|
1 |
p. 9-13
5 p.
|
artikel
|
| 49 |
Trial Design Strategies for Vascular-Targeted Therapy of Patients with Ovarian Cancer
|
Varughese, Mohini A.
|
|
2009
|
|
1 |
p. 24-30
7 p.
|
artikel
|
| 50 |
Use of Docetaxel After Paclitaxel Hypersensitivity Reaction in Epithelial Ovarian and Endometrial Cancer
|
Isonishi, Seiji
|
|
2009
|
|
1 |
p. 44-47
4 p.
|
artikel
|
| 51 |
VEGF in the Development of Ovarian Malignancy
|
Smerdel, Maja Patricia
|
|
2011
|
|
1 |
p. 19-25
7 p.
|
artikel
|
| 52 |
Weekly Administration of Paclitaxel and Carboplatin in the Treatment of Advanced Ovarian or Peritoneal Cancers With Poor Performance Status
|
Yunokawa, Mayu
|
|
2010
|
|
1 |
p. 47-51
5 p.
|
artikel
|
Tijdschrift beschrijving